Clinical Trial Update: Safety, Tolerability and Pharmacodynamics of QAX028 Compared to Open-label Tiotropium Bromide and Placebo in Mild-to-moderate Chronic Obstructive Pulmonary Disease (COPD) Patients. [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating safety, tolerability, and pharmacodynamics of the experimental drug QAX028 compared with open-label tiotropium bromide and placebo in m…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• QAX028
• tiotropium bromide (tiotropium)

Snippet

Sponsor: Novartis | Conditions: COPD | Phase 1 | Status: COMPLETED